| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4390 | Renzapride Hydrochloride | 5-HT3 antagonist and 5-HT4 agonist, also acting as a 5-HT2B antagonist |
|
| DCC4391 | Rep8839 | Novel bacterial methionyl t-RNA synthetase (MRS) inhibitor, hampering Plasmodium growth very effectively |
|
| DCC4392 | Repinotan Hydrochloride | Selective 5-HT1A receptor agonist |
|
| DCC4393 | Resazurin | Oxidation-reduction indicator in cell viability |
|
| DCC4394 | Resiniferatoxin | Potent VR1 vanilloid receptor agonist, activating protein kinase C |
|
| DCC4395 | Resorcinolnaphthalein | Angiotensin-converting enzyme 2 (ACE2) activator, acting as a modulator on RAAS and KKS activation during COVID-19 |
|
| DCC4396 | Resorufin-r1 | Red-absorbing, water-soluble, and iodinated resorufin derivative, being selectively activated with a monoamine oxidase (MAO) enzyme, showing high 1O 2 generation yields in aqueous solutions upon addition of MAO isoforms |
|
| DCC4397 | resveratrol-3-sulfate | Metabolite of Resveratrol |
|
| DCC4398 | Resveratrol-4’-sulfate | Metabolite of Resveratrol |
|
| DCC4399 | Retro-2.1 | Novel potent inhibitor of EBOV infection and entry |
|
| DCC4400 | Rev1/ubm2 Inhibitor | Novel inhibitor of the REV1/UbPCNA interaction, directly binding to REV1 UBM2 and preventing DNA damage tolerance (DDT) |
|
| DCC4401 | Revamilast | Novel phosphodiesterase IV (PDE4) inhibitor for the treatment of Asthma and Rheumatoid Arthritis |
|
| DCC4402 | Reveromycins Inducer Br-1 | Novel biomediator that induces reveromycins production at the wide range of concentrations without affecting cell growth |
|
| DCC4403 | Rf04289 | Novel TLR2 activator |
|
| DCC4404 | Rf3286 | Novel Highly Selective Neuropeptide FF1 Receptor Antagonist, Potently Preventing Opioid-Induced Hyperalgesia |
|
| DCC4405 | Rf470dl | Novel fluorescent D-amino acid for labeling peptidoglycans (PG) in live bacteria |
|
| DCC4406 | Rg-102240 | Gene switch ligand as a transcription inducer for use in induceable gene expression systems |
|
| DCC4407 | Rg7388-tco | Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition |
|
| DCC4408 | Rgb-286147 | Potent, selective & ATP-competitive inhibitor of Cdks |
|
| DCC4409 | Rgd-mimetic-1 | Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6 |
|
| DCC4410 | Rgd-ss-ca | Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity |
|
| DCC4411 | rgh-237 | Orally active, selective dopamine D3 receptor partial agonist |
|
| DCC4412 | Rgia-5524 | Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain |
|
| DCC4413 | rh01617 | Potent inhibitor of Kv1.5 potassium channel |
|
| DCC4414 | Rh02007 | Novel inhibitor of the human papillomavirus (HPV) E6 oncoprotein |
|
| DCC4415 | Rh-5849 | Novel Insect growth regulator, as potential insecticide to control olive fruit fly (Bactrocera oleae Rossi) |
|
| DCC4416 | Rhizoxin | Potent tubulin assembly and cancer cell growth inhibitor |
|
| DCC4417 | Rhlr Agonist S4 | Quorum sensing modulator as a RhlR agonist |
|
| DCC4418 | Rhlr Antagonist 30 | Novel potent and selective RhlR antagonist, strongly inhibiting biofilm formation, and reducing production of virulence factors in P. aeruginosa |
|
| DCC4419 | Rhlr Antagonist E22 | Quorum sensing modulator as a RhlR antagonist |
|
